Swedish Orphan Biovit Ord (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,929 | 134,875 | 27,331 | 36,576 | 113,847 |
| Receivables | 615,568 | 575,474 | 427,335 | 432,816 | 528,539 |
| Inventories | 350,087 | 330,201 | 313,929 | 347,878 | 360,392 |
| TOTAL | $984,584 | $1,110,911 | $768,595 | $817,270 | $1,002,777 |
| Non-Current Assets | |||||
| PPE Net | 25,812 | 27,153 | 29,324 | 36,576 | 40,698 |
| Investments And Advances | 12,906 | 11,991 | 14,994 | 13,411 | 12,959 |
| Intangibles | 4,047,991 | 3,965,288 | 3,937,686 | 3,973,779 | 4,098,074 |
| Other Non-Current Assets | 82,694 | 86,912 | 82,943 | 79,249 | 73,042 |
| TOTAL | $4,169,403 | $4,091,344 | $4,064,947 | $4,103,015 | $4,224,773 |
| Total Assets | $5,153,892 | $5,202,354 | $4,833,542 | $4,920,386 | $5,227,444 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 567,195 | 574,384 | 160,286 | 134,214 | 109,670 |
| Accounts payable and accrued liabilities | 59,750 | 124,073 | 34,259 | 52,730 | 58,370 |
| Accrued Expenses | N/A | 520,572 | N/A | N/A | N/A |
| Other current liabilities | 766,808 | 237,741 | 663,066 | 600,456 | 788,577 |
| TOTAL | $1,406,563 | $1,472,329 | $870,518 | $800,811 | $969,898 |
| Non-Current Liabilities | |||||
| Long Term Debt | 284,219 | 294,426 | 771,822 | 825,094 | 895,356 |
| Other Non-Current Liabilities | 435,267 | 430,589 | 454,381 | 450,393 | 447,250 |
| TOTAL | $1,086,972 | $1,101,298 | $1,584,450 | $1,648,054 | $1,713,279 |
| Total Liabilities | $2,493,535 | $2,573,727 | $2,454,873 | $2,448,763 | $2,683,069 |
| Shareholders' Equity | |||||
| Common Shares | 16,252 | 16,847 | N/A | N/A | N/A |
| Retained earnings | 1,627,781 | 1,565,086 | N/A | N/A | N/A |
| Other shareholders' equity | 41,491 | 34,784 | 2,378,668 | 2,471,521 | 2,544,375 |
| TOTAL | $2,660,357 | $2,628,627 | $2,378,668 | $2,471,521 | $2,544,375 |
| Total Liabilities And Equity | $5,153,892 | $5,202,354 | $4,833,541 | $4,920,284 | $5,227,444 |